Cargando…

Pharmacotherapeutic Potential of Natural Products to Target the SARS-CoV-2 PLpro Using Molecular Screening and Simulation Approaches

Because of the essential role of PLpro in the regulation of replication and dysregulation of the host immune sensing, it is considered a therapeutic target for novel drug development. To reduce the risk of immune evasion and vaccine effectiveness, small molecular therapeutics are the best complement...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sayaf, Abrar Mohammad, Ahmad, Hassaan, Aslam, Muhammad Ammar, Ghani, Sidra Abdul, Bano, Saira, Yousafi, Qudsia, Suleman, Muhammad, Khan, Abbas, Yeoh, Kar Kheng, Wei, Dong-Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037394/ https://www.ncbi.nlm.nih.gov/pubmed/36961512 http://dx.doi.org/10.1007/s12010-023-04466-1

Ejemplares similares

Investigation of the binding and dynamic features of A.30 variant revealed higher binding of RBD for hACE2 and escapes the neutralizing antibody: A molecular simulation approach
por: Shafiq, Athar, et al.
Publicado: (2022)

Exploring the natural products chemical space through a molecular search to discover potential inhibitors that target the hypoxia-inducible factor (HIF) prolyl hydroxylase domain (PHD)
por: Sayaf, Abrar Mohammad, et al.
Publicado: (2023)

Interaction of human dynein light chain 1 (DYNLL1) with enterochelin esterase (Salmonella typhimurium) and protective antigen (Bacillus anthraci) might be the potential cause of human infection
por: Yousafi, Qudsia, et al.
Publicado: (2020)

Bioinformatics analysis of the differences in the binding profile of the wild-type and mutants of the SARS-CoV-2 spike protein variants with the ACE2 receptor
por: Suleman, Muhammad, et al.
Publicado: (2021)

Inhibitors of SARS-CoV-2 PLpro
por: Calleja, Dale J., et al.
Publicado: (2022)

Pharmacotherapeutic targets in Alzheimer's disease
por: Biran, Yif'at, et al.
Publicado: (2009)

Mitochondrial Dysfunction in Gliomas: Pharmacotherapeutic Potential of Natural Compounds
por: Guntuku, Lalita, et al.
Publicado: (2016)

Subtractive Proteomics and Immuno-informatics Approaches for Multi-peptide Vaccine Prediction Against Klebsiella oxytoca and Validation Through In Silico Expression
por: Yousafi, Qudsia, et al.
Publicado: (2021)

Blocking key mutated hotspot residues in the RBD of the omicron variant (B.1.1.529) with medicinal compounds to disrupt the RBD-hACE2 complex using molecular screening and simulation approaches
por: Khan, Abbas, et al.
Publicado: (2022)

SARS-CoV-2: the many pros of targeting PLpro
por: McClain, Christopher B., et al.
Publicado: (2020)

Molecular analysis of V617F mutation in Janus kinase 2 gene of breast cancer patients
por: Karim, Sajjad, et al.
Publicado: (2019)

Docking Studies and Molecular Dynamics Simulations of Potential Inhibitors from the Brown Seaweed Sargassum polycystum (Phaeophyceae) against PLpro of SARS-CoV-2
por: Tassakka, Asmi Citra Malina A. R., et al.
Publicado: (2023)

Impact of Natural Compounds on Neurodegenerative Disorders: From Preclinical to Pharmacotherapeutics
por: Sharifi-Rad, Mehdi, et al.
Publicado: (2020)

The Future of Schizophrenia Pharmacotherapeutics: Not So Bleak
por: Carpenter, William T.
Publicado: (2012)

Novel pharmacotherapeutic treatments for cocaine addiction
por: Shorter, Daryl, et al.
Publicado: (2011)

Documentation of pharmacotherapeutic interventions of pharmacy students
por: King, Elicia D., et al.
Publicado: (2007)

Pharmacotherapeutics Applications and Chemistry of Chalcone Derivatives
por: Dhaliwal, Jagjit Singh, et al.
Publicado: (2022)

Challenges in the Pharmacotherapeutic Management of Pediatric Asthma
por: Ioniuc, Ileana, et al.
Publicado: (2022)

Clinical, Translational and Experimental Pharmacotherapeutics Advances
por: He, Zhiyao, et al.
Publicado: (2023)

Pharmacotherapeutics of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

Pharmacotherapeutic Approaches to Treatment of Muscular Dystrophies
por: Rawls, Alan, et al.
Publicado: (2023)

Broader Implications of Modeling and Simulation (M&S) Tools in Pharmacotherapeutic Decisions: A Cautionary Optimism
por: Chaturvedula, Ayyappa, et al.
Publicado: (2020)

Identification of Doxorubicin as Repurposing Inhibitory Drug for MERS-CoV PLpro
por: Alaofi, Ahmed L., et al.
Publicado: (2022)

A mini-review: positive impact of COVID-19 on Arial health and ecology
por: Naseer, Sidra, et al.
Publicado: (2022)

Comparative mutational analysis of SARS-CoV-2 isolates from Pakistan and structural-functional implications using computational modelling and simulation approaches
por: Shah, Abdullah, et al.
Publicado: (2022)

Phytochemical-Based Nano-Pharmacotherapeutics for Management of Burn Wound Healing
por: Qadir, Abdul, et al.
Publicado: (2021)

In silico annotation of unreviewed acetylcholinesterase (AChE) in some lepidopteran insect pest species reveals the causes of insecticide resistance
por: Yousafi, Qudsia, et al.
Publicado: (2021)

Structural-Dynamics and Binding Analysis of RBD from SARS-CoV-2 Variants of Concern (VOCs) and GRP78 Receptor Revealed Basis for Higher Infectivity
por: Khan, Abbas, et al.
Publicado: (2021)

Review of NVP and HG and Early Pharmacotherapeutic Intervention
por: Clark, Shannon M., et al.
Publicado: (2012)

Pharmacotherapeutic Options for Visceral Leishmaniasis—Current Scenario
por: Pandey, Krishna, et al.
Publicado: (2009)

A Comprehensive Review on Pharmacotherapeutics of Herbal Bioenhancers
por: Dudhatra, Ghanshyam B., et al.
Publicado: (2012)

Current and Emerging Pharmacotherapeutic Options for Smoking Cessation
por: Carson, Kristin V., et al.
Publicado: (2013)

Editorial of special issue on pharmacotherapeutics of digestive tumors
por: Fu, Liwu
Publicado: (2020)

Medical evaluation and pharmacotherapeutical strategies in management of urolithiasis
por: Ng, Derry Minyao, et al.
Publicado: (2021)

Pharmacotherapeutics of SARS-CoV-2 Infections
por: Kevadiya, Bhavesh D., et al.
Publicado: (2021)

Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2
por: Klemm, Theresa, et al.
Publicado: (2020)

6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro
por: Swaim, Caleb D., et al.
Publicado: (2021)

Exploring the medicinal potential of Dark Chemical Matters (DCM) to design promising inhibitors for PLpro of SARS-CoV-2 using molecular screening and simulation approaches
por: Khan, Abbas, et al.
Publicado: (2023)

Repurposing the antibacterial drugs for inhibition of SARS-CoV2-PLpro using molecular docking, MD simulation and binding energy calculation
por: Patel, Rohit, et al.
Publicado: (2021)

Virtual screening and molecular dynamics simulation analysis of Forsythoside A as a plant-derived inhibitor of SARS-CoV-2 3CLpro
por: Bibi, Shabana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f1cn0q7eedm7g354csju492tdp